286 related articles for article (PubMed ID: 35325804)
1. Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway.
Cai C; Guo Z; Chang X; Li Z; Wu F; He J; Cao T; Wang K; Shi N; Zhou H; Toan S; Muid D; Tan Y
Redox Biol; 2022 Jun; 52():102288. PubMed ID: 35325804
[TBL] [Abstract][Full Text] [Related]
2. Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis.
Zou R; Shi W; Qiu J; Zhou N; Du N; Zhou H; Chen X; Ma L
Cardiovasc Diabetol; 2022 Jun; 21(1):106. PubMed ID: 35705980
[TBL] [Abstract][Full Text] [Related]
3. NR4A1 aggravates the cardiac microvascular ischemia reperfusion injury through suppressing FUNDC1-mediated mitophagy and promoting Mff-required mitochondrial fission by CK2α.
Zhou H; Wang J; Zhu P; Zhu H; Toan S; Hu S; Ren J; Chen Y
Basic Res Cardiol; 2018 May; 113(4):23. PubMed ID: 29744594
[TBL] [Abstract][Full Text] [Related]
4. Mst1 promotes cardiac ischemia-reperfusion injury by inhibiting the ERK-CREB pathway and repressing FUNDC1-mediated mitophagy.
Yu W; Xu M; Zhang T; Zhang Q; Zou C
J Physiol Sci; 2019 Jan; 69(1):113-127. PubMed ID: 29961191
[TBL] [Abstract][Full Text] [Related]
5. Electroacupuncture preconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting mitophagy mediated by the mTORC1-ULK1-FUNDC1 pathway.
Xiao Y; Chen W; Zhong Z; Ding L; Bai H; Chen H; Zhang H; Gu Y; Lu S
Biomed Pharmacother; 2020 Jul; 127():110148. PubMed ID: 32344255
[TBL] [Abstract][Full Text] [Related]
6. Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission.
Zhou H; Wang S; Zhu P; Hu S; Chen Y; Ren J
Redox Biol; 2018 May; 15():335-346. PubMed ID: 29306791
[TBL] [Abstract][Full Text] [Related]
7. Melatonin suppresses platelet activation and function against cardiac ischemia/reperfusion injury via PPARγ/FUNDC1/mitophagy pathways.
Zhou H; Li D; Zhu P; Hu S; Hu N; Ma S; Zhang Y; Han T; Ren J; Cao F; Chen Y
J Pineal Res; 2017 Nov; 63(4):. PubMed ID: 28749565
[TBL] [Abstract][Full Text] [Related]
8. Empagliflozin activates Wnt/β-catenin to stimulate FUNDC1-dependent mitochondrial quality surveillance against type-3 cardiorenal syndrome.
Cai C; Wu F; Zhuang B; Ou Q; Peng X; Shi N; Peng L; Li Z; Wang J; Cai S; Tan Y
Mol Metab; 2022 Oct; 64():101553. PubMed ID: 35863636
[TBL] [Abstract][Full Text] [Related]
9. Shuangshen ningxin formula attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial function.
Liu Z; Han X; You Y; Xin G; Li L; Gao J; Meng H; Cao C; Liu J; Zhang Y; Li L; Fu J
J Ethnopharmacol; 2024 Apr; 323():117690. PubMed ID: 38195019
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of HINT2 on mitochondrial function via repressing MCU complex activation attenuates cardiac microvascular ischemia-reperfusion injury.
Li S; Chen J; Liu M; Chen Y; Wu Y; Li Q; Ma T; Gao J; Xia Y; Fan M; Chen A; Lu D; Su E; Xu F; Chen Z; Qian J; Ge J
Basic Res Cardiol; 2021 Dec; 116(1):65. PubMed ID: 34914018
[TBL] [Abstract][Full Text] [Related]
11. Exercise protects aged mice against coronary endothelial senescence via FUNDC1-dependent mitophagy.
Ma L; Li K; Wei W; Zhou J; Li Z; Zhang T; Wangsun Y; Tian F; Dong Q; Zhang H; Xing W
Redox Biol; 2023 Jun; 62():102693. PubMed ID: 37030149
[TBL] [Abstract][Full Text] [Related]
12. Mff-Dependent Mitochondrial Fission Contributes to the Pathogenesis of Cardiac Microvasculature Ischemia/Reperfusion Injury via Induction of mROS-Mediated Cardiolipin Oxidation and HK2/VDAC1 Disassociation-Involved mPTP Opening.
Zhou H; Hu S; Jin Q; Shi C; Zhang Y; Zhu P; Ma Q; Tian F; Chen Y
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28288978
[TBL] [Abstract][Full Text] [Related]
13. NLRX1/FUNDC1/NIPSNAP1-2 axis regulates mitophagy and alleviates intestinal ischaemia/reperfusion injury.
Li S; Zhou Y; Gu X; Zhang X; Jia Z
Cell Prolif; 2021 Mar; 54(3):e12986. PubMed ID: 33432610
[TBL] [Abstract][Full Text] [Related]
14. [Tetrahydropalmatine inhibiting mitophagy through ULK1/FUNDC1 pathway to alleviate hypoxia/reoxygenation injury in H9c2 cells].
Xin GJ; Liu ZX; Chen YY; Zhang HY; Guo F; Peng H; Li L; Han X; Liu JX; Fu JH
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1286-1294. PubMed ID: 38621976
[TBL] [Abstract][Full Text] [Related]
15. Fundc1-dependent mitophagy is obligatory to ischemic preconditioning-conferred renoprotection in ischemic AKI via suppression of Drp1-mediated mitochondrial fission.
Wang J; Zhu P; Li R; Ren J; Zhou H
Redox Biol; 2020 Feb; 30():101415. PubMed ID: 31901590
[TBL] [Abstract][Full Text] [Related]
16. SGLT2 inhibitor empagliflozin alleviates cardiac remodeling and contractile anomalies in a FUNDC1-dependent manner in experimental Parkinson's disease.
Yu W; Wang L; Ren WY; Xu HX; Wu NN; Yu DH; Reiter RJ; Zha WL; Guo QD; Ren J
Acta Pharmacol Sin; 2024 Jan; 45(1):87-97. PubMed ID: 37679644
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of cardiac ischemia reperfusion injury is associated with CK2α-disturbed mitochondrial homeostasis via suppression of FUNDC1-related mitophagy.
Zhou H; Zhu P; Wang J; Zhu H; Ren J; Chen Y
Cell Death Differ; 2018 Jun; 25(6):1080-1093. PubMed ID: 29540794
[TBL] [Abstract][Full Text] [Related]
18. Melatonin protects cardiac microvasculature against ischemia/reperfusion injury via suppression of mitochondrial fission-VDAC1-HK2-mPTP-mitophagy axis.
Zhou H; Zhang Y; Hu S; Shi C; Zhu P; Ma Q; Jin Q; Cao F; Tian F; Chen Y
J Pineal Res; 2017 Aug; 63(1):. PubMed ID: 28398674
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum to "Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway" [Redox Biol. 52 (2022) 102288].
Cai C; Guo Z; Chang X; Li Z; Wu F; He J; Cao T; Wang K; Shi N; Zhou H; Toan S; Muid D; Tan Y
Redox Biol; 2023 Jul; 63():102738. PubMed ID: 37202250
[No Abstract] [Full Text] [Related]
20. Overexpression of PLK1 relieved the myocardial ischemia-reperfusion injury of rats through inducing the mitophagy and regulating the p-AMPK/FUNDC1 axis.
Mao S; Tian S; Luo X; Zhou M; Cao Z; Li J
Bioengineered; 2021 Dec; 12(1):2676-2687. PubMed ID: 34115550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
